BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
about
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
@en
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
@nl
type
label
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
@en
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
@nl
prefLabel
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
@en
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
@en
P2093
Chiao-Yun Chu
Jimmy Yu-Wai Chan
John Zeng-Hong Li
Si-Qi Chen
P2860
P304
P356
10.1002/CAM4.982
P407
P577
2017-01-13T00:00:00Z